<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0A0DE806-2BAC-4CEC-BD38-781D63A5F50B"><gtr:id>0A0DE806-2BAC-4CEC-BD38-781D63A5F50B</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:surname>Oakley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900535"><gtr:id>AD51F6B6-0DEC-4E3E-A502-72F327376867</gtr:id><gtr:title>RelA Serine 536 phosphorylation as a selective therapeutic target in fibrotic disease.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900535</gtr:grantReference><gtr:abstractText>It is estimated that fibrosis is an underlying cause of up to 40% of all deaths in the western world. Fibrosis or tissue scarring caused by chronic injury can occur in many organs including; liver, lung, kidney and skin. Specifically for liver disease over 12,000 people die every year in the UK and these figures will continue to rise due to increased obesity related liver disease, excess alcohol consumption and hepatitis infection. Currently there are no proven effective anti-fibrotic drugs therefore transplantation is the only alternative for patients where the underlying cause of disease can not be treated. Therefore liver fibrosis is and will continue to be a major financial and healthcare burden on the NHS. This project aims to inhibit a specific modification of a protein in the scar promoting cells that promotes their survival. Once scar producing cells are removed from the liver the scar can be degraded and disease progression will be prevented. I aim to understand is the signalling events regulating this modification and to test if inhibiting it will reverse fibrosis. Finally I will establish whether this is a critical signalling event that promotes survival of scar forming cells in organs which are susceptible to fibrosis i.e. lung, kidney and skin.</gtr:abstractText><gtr:technicalSummary>The vision for this project is to therapeutically exploit a specific post translational modification of the RelA subunit of NF-kB to treat organ fibrosis. I aim to discover if RelA serine 536 phosphorylation (P-Ser536-RelA) is a genuine anti-fibrotic target and a predictive indicator of fibrosis which will regress after
pharmacological blockade of the renin-angiotensin II system (RAS). This work is based on my recent observations that constitutive P-Ser536-RelA is a characteristic of both rodent and human hepatic myofibroblasts (HM) linked with their survival and fibrosis. I discovered that HM P-Ser536-RelA is under autocrine control of the RAS and that inhibition of this pathway in two rodent models of liver fibrosis was associated with reduced P-Ser536-RelA and regression of disease. This mark was highly expressed in cirrhotic Hepatitis C patients and was a predictive indicator of patients whose fibrosis will regress in response to treatment with losartan. However, many questions remain, as not all of the patients in this study responded to losartan treatment despite P-Ser536-RelA being present. This suggests the existence of other P-Ser536-RelA signalling mechanisms in myofibroblasts. Functional biochemistry defining the signalling pathways which induce P-Ser536-RelA and direct targeting of this modification in vivo are now required. Quantifying the expression levels and localisation of P-Ser536-RelA in human diseased tissue from multiple fibrotic disorders is required to show that it has potential to be a generic anti-fibrotic target. In this project I will determine if P-Ser536-RelA in human HM is a critical integrator of damage associated signals and if it promotes HM survival in different types of liver disease. I will use cell permeable serine 536 phosphorylation competing peptides to selectively target this event in three progressive in vivo models of liver damage to prove that this will be an effective anti-fibrotic strategy in fibrosis where injury persists, as this parallels the clinical problem. To elucidate if this modification in myofibroblasts is a common signalling event that promotes their survival in organ fibrosis P-Ser536-RelA associated with myofibroblasts will be quantified in biopsy slides from lung, kidney and skin fibrosis. To further translate my discoveries on NF-kB to fibrogenesis in other organs, I will determine if RAS inhibits and P-Ser536-RelA competing peptides can influence the phenotype and lifespan of human lung (myo)fibroblasts. This work will further our understanding of common mechanisms which underpin the pathogenesis of fibrotic disease and could potentially be developed as a generic anti-fibrotic target.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-29</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>403895</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Leading Edge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FDDAA68C-1959-4BB0-AE94-2D1EE458CE3B</gtr:id><gtr:impact>6 students visited the lab and undertook a project on liver disease, this included a lab based project, poster making session, social aspect (web based research and questionaire) and finally a conference where the students present posters and talks.

Schools have asked for this to be an annual event.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>leading edge 2013 - love your liver</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>10E21877-DCA8-486A-8D2C-C3BCEEBBA29A</gtr:id><gtr:impact>Eighty school children participated in leading edge this year. they attend a series of workshops from scientific skills, communication skills and lab visits to experience &amp;quot;real research&amp;quot;. The students presented their project at a grand finale event and the British Science festival. 
Six of these students undertook a liver project with myself.

yes - requests for work experiences/shadowing or lab visits for schools and sixth for are facilitated by the institute and fibrosis lab.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://research.ncl.ac.uk/fibrosislab/newsevents/publicengagement/leadingedge/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How do scars form and why do they go away?</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>033BAF67-2E0B-4A54-98A2-F18473F6A111</gtr:id><gtr:impact>Leading Edge 2012-2013: Six pupils from a local school completed a 3 month project on liver disease. The event includes school visits by academics, a 2 day visit by the pupils to the fibrosis laboratory, science skills workshop, communication and presentation skills workshop, poster making session and a grand finale event. 

Sparked questions and discussion about liver disease, the models we use to understand the disease process and the use of animals in liver fibrosis research with students in the year prior to selecting their GCSE options.

November 2012-October 2013 year include;

Leading Edge 2012-2013: Six pupils from a local school completed a 3 month project on liver disease. The event includes school visits by academics, a 2 day visit by the pupils to the fibrosis laboratory, science skills workshop, communication and presentation skills workshop, poster making session and a grand finale event. 



British science festival - This was a one day event comprised of mini-workshops for school children to learn about liver disease at the British science festival. 



Leading Edge 2013-2014: The event will be officially launched on 15th January 2014. This year the project from the fibrosis laboratory will be jointly run by Oakley, Borthwick and Sheerin is; PCS: Precision cut slices, Confocal microscopy, Stunning data.

The project will investigate &amp;quot;How do scars form and why do they go away?&amp;quot;



Further details about our public engagement events can be found at http://research.ncl.ac.uk/fibrosislab/newsevents/publicengagement/</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://research.ncl.ac.uk/fibrosislab/newsevents/publicengagement/</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science on a plate</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3EBD14E2-F3FE-4B67-BEA2-86ECEDC4CB10</gtr:id><gtr:impact>100 secondary school pupils attended a workshop on &amp;quot;what happens to your dinner?&amp;quot; this included MRI theory, exercise physiology and liver disease. the workshop was interactive.

The schools asked fo rthe event to be repeated, this is now an anuual event ruin by the Institute of cellular medicine at Newcastle University.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>british science festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EE294B4E-B652-4308-ABB3-77FB7462A679</gtr:id><gtr:impact>four workshops over the course of the day. 20 school children took part in each workshops and leanred about liver disease

no</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.britishscienceassociation.org/british-science-festival</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science on a plate - 40 school pupils visited a science workshop at the university.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EC15614C-EACE-42E6-BE36-1D99D93F14E3</gtr:id><gtr:impact>40 school pupils visited a science workshop at the university called &amp;quot;Science on a Plate&amp;quot; with the theme of understanding what happens to the food we eat. The workshop consisted of talks on MRI imaging, liver disease and exercise physiology and interactive practical sessions in liver microscopy and exercise physiology.

the session will be run again</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ncl.ac.uk/icm/public/school/science/index.htm</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leading edge - PCS project</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F435F823-B961-489F-B160-8B2BC62D08A2</gtr:id><gtr:impact>10 Students from St Marys high school undertook a 5 month long project with the fibrosis group looking at to develop system to use precision cut slice cultures as a way to model liver, lung and kidney fibrosis and replace animal models. 

The project involved academics visiting the schools to give lectures, a 4 day lab based project in the fibrosis lab, poster and presentation workshops, communication workshops and a grand finale event where the school children presented to their teachers, parents and peers from 10 local schools also involved in the scheme. 

The children presented their research at the institute research day. 

Finally the pupils visited the institute of transplantation to hear from transplant co-ordinators, transplant nurses, doctors and surgeons about organ (liver, lung and kidney) and to have a q&amp;amp;A about careers in medicine.

increase the understanding of chronic disease and fibrosis. Motivate the children to pursue careers in science by exposing the students to &amp;quot;real research&amp;quot;

stimulate discussion about drug discovery and tissue fibrosis and using non-animal models for fibrosis drug discovery.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://research.ncl.ac.uk/fibrosislab/newsevents/publicengagement/leadingedge/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>women in science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>549D2409-0D43-4558-A4D9-F421A13AC3DB</gtr:id><gtr:impact>presentation about women's careers in science ( one basic science (presented by me) and one clinical talk) at the BASL annual meeting. followed by group discussion. The audience was a mix of PHD students, post docs and clinical fellows.

N/A</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.basl.org.uk/annual-meeting/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>love your liver</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F5CA9AAF-5CE0-4239-ABAB-07AE8B08679F</gtr:id><gtr:impact>60 pupils attended an interactive workshop

The institute are now hosting work shadowing/experience from local schools and sixth form colleges.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.ncl.ac.uk/icm/public/school/science/index.htm</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3R pilot grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>NC/K000748/1</gtr:fundingRef><gtr:id>A8C739E2-C429-470F-BB36-88F8DDBE32FA</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DBABD22-C13B-4E32-B4EA-3B49AE139F38"><gtr:id>9DBABD22-C13B-4E32-B4EA-3B49AE139F38</gtr:id><gtr:title>A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74b67d302f01664c5635d70bc831a2b2"><gtr:id>74b67d302f01664c5635d70bc831a2b2</gtr:id><gtr:otherNames>Moles A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67F00E79-8B1F-4EA9-A214-71483AC9E71C"><gtr:id>67F00E79-8B1F-4EA9-A214-71483AC9E71C</gtr:id><gtr:title>Multigenerational epigenetic adaptation of the hepatic wound-healing response.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49e503d6853ae389445c83e0bc10a26f"><gtr:id>49e503d6853ae389445c83e0bc10a26f</gtr:id><gtr:otherNames>Zeybel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C303A1F6-AC36-437A-B892-09626176C8ED"><gtr:id>C303A1F6-AC36-437A-B892-09626176C8ED</gtr:id><gtr:title>Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/031cd1754aad510570d89470b76ef670"><gtr:id>031cd1754aad510570d89470b76ef670</gtr:id><gtr:otherNames>Robinson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFBE19FC-40F7-419C-8F54-8CE42A28D641"><gtr:id>EFBE19FC-40F7-419C-8F54-8CE42A28D641</gtr:id><gtr:title>Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74b67d302f01664c5635d70bc831a2b2"><gtr:id>74b67d302f01664c5635d70bc831a2b2</gtr:id><gtr:otherNames>Moles A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/747255A2-79BC-4511-80B5-F49139A6339A"><gtr:id>747255A2-79BC-4511-80B5-F49139A6339A</gtr:id><gtr:title>The c-Rel subunit of NF-?B regulates epidermal homeostasis and promotes skin fibrosis in mice.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4665f014be53c0437109ca658234226c"><gtr:id>4665f014be53c0437109ca658234226c</gtr:id><gtr:otherNames>Fullard N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F35837A-714B-4B85-A49D-C9071EA7B77C"><gtr:id>9F35837A-714B-4B85-A49D-C9071EA7B77C</gtr:id><gtr:title>TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0021d749bb4d4bc9912bbd6bdd4fb28a"><gtr:id>0021d749bb4d4bc9912bbd6bdd4fb28a</gtr:id><gtr:otherNames>Vyrla D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F5A2AE0-3A2F-4E9A-80F5-B027E34F5AA5"><gtr:id>5F5A2AE0-3A2F-4E9A-80F5-B027E34F5AA5</gtr:id><gtr:title>Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3a8119b964a9f188f16563f717365b4"><gtr:id>c3a8119b964a9f188f16563f717365b4</gtr:id><gtr:otherNames>Amer AO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05D91FAE-B7BE-4ADB-A9C5-FD0155CD3959"><gtr:id>05D91FAE-B7BE-4ADB-A9C5-FD0155CD3959</gtr:id><gtr:title>Serotonin paracrine signaling in tissue fibrosis.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43b212cc245f89c717c6028051e87a2d"><gtr:id>43b212cc245f89c717c6028051e87a2d</gtr:id><gtr:otherNames>Mann DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97E7FBFC-F2DC-46BA-88DC-EE8B6BB563A9"><gtr:id>97E7FBFC-F2DC-46BA-88DC-EE8B6BB563A9</gtr:id><gtr:title>The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/031cd1754aad510570d89470b76ef670"><gtr:id>031cd1754aad510570d89470b76ef670</gtr:id><gtr:otherNames>Robinson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05254705-B8D4-478F-A5CD-F113167C1F4B"><gtr:id>05254705-B8D4-478F-A5CD-F113167C1F4B</gtr:id><gtr:title>A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-?B-dependent liver regeneration and cancer.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74b67d302f01664c5635d70bc831a2b2"><gtr:id>74b67d302f01664c5635d70bc831a2b2</gtr:id><gtr:otherNames>Moles A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C24C0D40-870C-4E3B-8CB7-40E1B84ECC55"><gtr:id>C24C0D40-870C-4E3B-8CB7-40E1B84ECC55</gtr:id><gtr:title>The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e25f25b5e6e4e3e42f9e0febbea4b4b"><gtr:id>8e25f25b5e6e4e3e42f9e0febbea4b4b</gtr:id><gtr:otherNames>Gieling RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21371DA2-C51C-4926-8F70-CE4D20601DF6"><gtr:id>21371DA2-C51C-4926-8F70-CE4D20601DF6</gtr:id><gtr:title>A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5447095432f66679fa5b121f0029e641"><gtr:id>5447095432f66679fa5b121f0029e641</gtr:id><gtr:otherNames>Luli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EB20AFD-6DCF-4FF7-833E-FCE0755D9343"><gtr:id>3EB20AFD-6DCF-4FF7-833E-FCE0755D9343</gtr:id><gtr:title>The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/493631e7f6cb041a80b042e43d15f759"><gtr:id>493631e7f6cb041a80b042e43d15f759</gtr:id><gtr:otherNames>Elsharkawy AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6D73E29-AAC5-4F3A-83EC-DB78FDDA3A3A"><gtr:id>B6D73E29-AAC5-4F3A-83EC-DB78FDDA3A3A</gtr:id><gtr:title>BAG-1 interacts with the p50-p50 homodimeric NF-?B complex: implications for colorectal carcinogenesis.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fbc3b595796d4121be2f266752f8a3a"><gtr:id>5fbc3b595796d4121be2f266752f8a3a</gtr:id><gtr:otherNames>Southern SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/315F321B-08AB-4567-98B5-2A826B3231B8"><gtr:id>315F321B-08AB-4567-98B5-2A826B3231B8</gtr:id><gtr:title>Roles of c-Rel signalling in inflammation and disease.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4665f014be53c0437109ca658234226c"><gtr:id>4665f014be53c0437109ca658234226c</gtr:id><gtr:otherNames>Fullard N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/654E8F93-71B7-4144-8905-EC0755A99226"><gtr:id>654E8F93-71B7-4144-8905-EC0755A99226</gtr:id><gtr:title>Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor-induced TIMP-1 gene transcription in hepatic stellate cells in mice.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f5ad466f939c0b0392cd79085389ec1"><gtr:id>3f5ad466f939c0b0392cd79085389ec1</gtr:id><gtr:otherNames>Perugorria MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77D8F3D3-F81E-4658-9E04-5DA1A362CD03"><gtr:id>77D8F3D3-F81E-4658-9E04-5DA1A362CD03</gtr:id><gtr:title>Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5cf06d39af5e60cd7619f648bf365985"><gtr:id>5cf06d39af5e60cd7619f648bf365985</gtr:id><gtr:otherNames>Fox C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B49D5FD-90A6-495F-BFA7-67225FB6BAFE"><gtr:id>8B49D5FD-90A6-495F-BFA7-67225FB6BAFE</gtr:id><gtr:title>Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae7b1ede0ee406a2e73b727d97146d1f"><gtr:id>ae7b1ede0ee406a2e73b727d97146d1f</gtr:id><gtr:otherNames>Ebrahimkhani MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31402C6D-4A06-4DEB-AD84-C0F59A14F5AF"><gtr:id>31402C6D-4A06-4DEB-AD84-C0F59A14F5AF</gtr:id><gtr:title>Chronic inflammation induces telomere dysfunction and accelerates ageing in mice.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be2bfba42b3fd25c952e5310dad46c14"><gtr:id>be2bfba42b3fd25c952e5310dad46c14</gtr:id><gtr:otherNames>Jurk D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1AB0E35F-6CAC-47E5-985A-2341ECD59811"><gtr:id>1AB0E35F-6CAC-47E5-985A-2341ECD59811</gtr:id><gtr:title>Mechanisms and biomarkers of apoptosis in liver disease and fibrosis.</gtr:title><gtr:parentPublicationTitle>International journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6eb7b0026a063b35ba3f32834c8de178"><gtr:id>6eb7b0026a063b35ba3f32834c8de178</gtr:id><gtr:otherNames>Chakraborty JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E050686-2FAC-4EB4-B891-514F855BE97D"><gtr:id>2E050686-2FAC-4EB4-B891-514F855BE97D</gtr:id><gtr:title>Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f5ad466f939c0b0392cd79085389ec1"><gtr:id>3f5ad466f939c0b0392cd79085389ec1</gtr:id><gtr:otherNames>Perugorria MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44BB57CB-0606-4A28-8C31-0DB47E36B293"><gtr:id>44BB57CB-0606-4A28-8C31-0DB47E36B293</gtr:id><gtr:title>A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49e503d6853ae389445c83e0bc10a26f"><gtr:id>49e503d6853ae389445c83e0bc10a26f</gtr:id><gtr:otherNames>Zeybel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CACAF8E2-058F-4262-8A36-F06D0626F3FD"><gtr:id>CACAF8E2-058F-4262-8A36-F06D0626F3FD</gtr:id><gtr:title>The NF-?B subunit c-Rel stimulates cardiac hypertrophy and fibrosis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c33a2b5ad5edbc32db1da1d3603c66f"><gtr:id>8c33a2b5ad5edbc32db1da1d3603c66f</gtr:id><gtr:otherNames>Gaspar-Pereira S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7810E4C1-5A0A-434E-B0F7-1DA553202AA2"><gtr:id>7810E4C1-5A0A-434E-B0F7-1DA553202AA2</gtr:id><gtr:title>NF?B1 is a suppressor of neutrophil-driven hepatocellular carcinoma.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b27d36db19d0e467a6921245842cd030"><gtr:id>b27d36db19d0e467a6921245842cd030</gtr:id><gtr:otherNames>Wilson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4B26881-A002-4DD9-81F6-999590947CEE"><gtr:id>C4B26881-A002-4DD9-81F6-999590947CEE</gtr:id><gtr:title>Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8660600ed00a4ad9d4729870703f646"><gtr:id>f8660600ed00a4ad9d4729870703f646</gtr:id><gtr:otherNames>Pritchett J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900535</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>